본문 바로가기
KERD
논문KCI 등재

Elevated Serum Galectin-1 and Galectin-3 Levels in Children With Specific Learning Disorder: A Case Control Study

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류정신과학

초록

Objective Specific learning disorder (SLD) is a neurodevelopmental disorder in which underlying pathogenesis and etiological factors are not fully understood. Neuroinflammatory response (measured with serum levels of galectin-1 and galectin-3), which is associated with learning and memory, may play an important role in the etiopathogenesis of SLD. Aim of the present study is to examine whether serum galectin-1 and galectin-3 levels are related to SLD.Methods The current study consisted of 42 treatment-naive children with SLD and 42 control subjects. All of the subjects were assessed using semi-structured psychiatric examination to diagnose SLD and exclude attention-deficit hyperactivity disorder. Serum galectin-1 and galectin-3 levels were measured via venous blood samples.Results The SLD and control group did not differ significantly in terms of age, sex, and body mass index (BMI). The SLD group had significantly higher serum levels of galectin-1 (8.78±2.97 vs. 7.40±2.03, p=0.019) and galectin-3 (1.86±0.93 vs. 1.32±0.69, p=0.003) than the control group when controlled for age, sex, and BMI.Conclusion Higher serum levels of galectin-1 and galectin-3 in children with SLD may indicate the role of neuroinflammatory response in the pathogenesis of SLD. Other mechanisms involving galectin-1 and galectin-3 related to learning may play a part in the etiology of SLD.

Abstract

Objective Specific learning disorder (SLD) is a neurodevelopmental disorder in which underlying pathogenesis and etiological factors are not fully understood. Neuroinflammatory response (measured with serum levels of galectin-1 and galectin-3), which is associated with learning and memory, may play an important role in the etiopathogenesis of SLD. Aim of the present study is to examine whether serum galectin-1 and galectin-3 levels are related to SLD.Methods The current study consisted of 42 treatment-naive children with SLD and 42 control subjects. All of the subjects were assessed using semi-structured psychiatric examination to diagnose SLD and exclude attention-deficit hyperactivity disorder. Serum galectin-1 and galectin-3 levels were measured via venous blood samples.Results The SLD and control group did not differ significantly in terms of age, sex, and body mass index (BMI). The SLD group had significantly higher serum levels of galectin-1 (8.78±2.97 vs. 7.40±2.03, p=0.019) and galectin-3 (1.86±0.93 vs. 1.32±0.69, p=0.003) than the control group when controlled for age, sex, and BMI.Conclusion Higher serum levels of galectin-1 and galectin-3 in children with SLD may indicate the role of neuroinflammatory response in the pathogenesis of SLD. Other mechanisms involving galectin-1 and galectin-3 related to learning may play a part in the etiology of SLD.

참고문헌 (50)

  1. American Psychiatric Association, "Diagnostic and statistical manual of mental disorders" (2013), American Psychiatric Association
  2. Kovas Y, "The genetic and environmental origins of learning abilities and disabilities in the early school years : I. INTRODUCTION", Monogr Soc Res Child Dev, 72, pp.1~13 (2007)
  3. Leffa DT, "A review on the role of inflammation in attention-deficit", hyperactivity disorder, 2019, pp.25, 328~333
  4. Dunn GA, "Neuroinflammation as a risk factor for attention deficit hyperactivity disorder", Pharmacol Biochem Behav, 182, pp.22~34 (2019)
  5. Estes ML, "Immune mediators in the brain and peripheral tissues in autism spectrum disorder", Nat Rev Neurosci, 16, pp.469~486 (2015)
  6. Abbott RD, "Patterns of biomarkers for three phenotype profiles of persisting specific learning disabilities during middle childhood and early adolescence : a preliminary study", Biomark Genes, 1, pp.103~ (2017)
  7. Serrallach B, "Neural biomarkers for dyslexia, ADHD, and ADD in the auditory cortex of children", Front Neurosci, 10, pp.324~ (2016)
  8. Bilac O, "Evaluation of the role of inflammation in specific learning disabilities", Turk J Child Adolesc Ment Health, 28, pp.60~64 (2021)
  9. Yang QQ, "Neuroinflammation in the central nervous system : symphony of glial cells", Glia, 67, pp.1017~1035 (2019)
  10. Réus GZ, "The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders", Neuroscience, 300, pp.141~154 (2015)
  11. Hassan W, "Association of oxidative stress with psychiatric disorders", Curr Pharm Des, 22, pp.2960~2974 (2016)
  12. Belmadani A, "Chemokines regulate the migration of neural progenitors to sites of neuroinflammation", J Neurosci, 26, pp.3182~3191 (2006)
  13. Sen S, "Serum brain-derived neurotrophic factor, depression, and antidepressant medications : meta-analyses and implications", Biol Psychiatry, 64, pp.527~532 (2008)
  14. Kronfol Z, "Cytokines and the brain : implications for clinical psychiatry", Am J Psychiatry, 157, pp.683~694 (2000)
  15. Yirmiya R, "Immune modulation of learning, memory, neural plasticity and neurogenesis", Brain Behav Immun, 25, pp.181~213 (2011)
  16. Cornell J, "Microglia regulation of synaptic plasticity and learning and memory", Neural Regen Res, 17, pp.705~716 (2022)
  17. Savitz J, "Interoception and inflammation in psychiatric disorders", Biol Psychiatry Cogn Neurosci Neuroimaging, 3, pp.514~524 (2018)
  18. Sakaguchi M, "Impaired spatial and contextual memory formation in galectin-1 deficient mice", Mol Brain, 4, pp.33~ (2011)
  19. Srejovic I, "Galectin-3 : roles in neurodevelopment, neuroinflammation, and behavior", Biomolecules, 10, pp.798~ (2020)
  20. Kaltner H, "Galectin-1 and galectin-3 in fetal development of bovine respiratory and digestive tracts", Cell Tissue Res, 307, pp.35~46 (2002)
  21. Egnaczyk GF, "Proteomic analysis of the reactive phenotype of astrocytes following endothelin-1 exposure", Proteomics, 3, pp.689~698 (2003)
  22. McGraw J, "Regulation of neuronal and glial galectin-1 expression by peripheral and central axotomy of rat primary afferent neurons", Exp Neurol, 195, pp.103~114 (2005)
  23. Wada M, "Decreased galectin-1 immunoreactivity of the skin in amyotrophic lateral sclerosis", J Neurol Sci, 208, pp.67~70 (2003)
  24. Dumic J, "Galectin-3 : an open-ended story", Biochim Biophys Acta, 1760, pp.616~635 (2006)
  25. Di Lella S, "When galectins recognize glycans : from biochemistry to physiology and back again", Biochemistry, 50, pp.7842~7857 (2011)
  26. Sciacchitano S, "Galectin-3 : one molecule for an alphabet of diseases, from A to Z", Int J Mol Sci, 19, pp.379~ (2018)
  27. Shin T, "The pleiotropic effects of galectin-3 in neuroinflammation : a review", Acta Histochem, 115, pp.407~411 (2013)
  28. Lalancette-Hébert M, "Galectin-3 is required for resident microglia activation and proliferation in response to ischemic injury", J Neurosci, 32, pp.10383~10395 (2012)
  29. Rahimian R, "Galectin-3 : mediator of microglia responses in injured brain", Drug Discov Today, 23, pp.375~381 (2018)
  30. Kajitani K, "Serum galectin-3, but not galectin-1, levels are elevated in schizophrenia: implications for the role of inflammation", Psychopharmacology(Berl), 234, pp.2919~2927 (2017)
  31. Borovcanin MM, "IL-33", ST2 pathway and galectin-3 as a new analytes in pathogenesis and cardiometabolic risk evaluation in psychosis, 2018, pp.9, 271~
  32. Yüksel RN, "Galectin-1 and galectin-3 levels in patients with schizophrenia and their unaffected siblings", Psychiatr Q, 91, pp.715~725 (2020)
  33. Ümit Is¸ ık, "Serum Galectin-3 Levels in Children with Attention-Deficit", Hyperactivity Disorder, 2020, pp.17(3), 256~261[DOI]
  34. Iwamoto M, "The galectin-1 level in serum as a novel marker for stress", Glycoconj J, 27, pp.419~425 (2010)
  35. Margari L, "Neuropsychopathological comorbidities in learning disorders", BMC Neurol, 13, pp.198~ (2013)
  36. Leiman M, "Are developmental learning disorders risk factors for late-onset Alzheimer’s disease?", Alzheimers Dement, 17, pp.e052203~ (2021)
  37. Savasır I, "Manual for the Wechsler Intelligence Scale for Children—Revised (WISC-R)" (1995), Turkish Psychology Association Publication
  38. Korkmazlar Ü, "Specific learning disorder between 6–11 years old primary school children and diagnostic methods", pp.1992
  39. Turgut Turan S, "Using neuropsychometric measurements in the differential diagnosis of specific learning disability", Noro Psikiyatr Ars, 53, pp.144~151 (2016)
  40. Chambers WJ, "The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version", Arch Gen Psychiatry, 42, pp.696~702 (1985)
  41. Ünal F, "Reliability and validity of the schedule for affective disorders and schizophrenia for school-age children-present and lifetime version, DSM-5 November 2016-Turkish adaptation (K-SADSPL-DSM-5-T)", Turk Psikiyatri Derg, 30, pp.42~50 (2019)
  42. Kaner S, "Conners parent rating scale-revised short: Turkish standardization study", Arch Neuropsychiatry, 50, pp.100~109 (2013)
  43. Wechsler D, "Manual for the Wechsler Intelligence Scale for Children—Revised" (1974), Psychological Corporation
  44. Swanson HL, "Handbook of learning disabilities", pp.214~238 (2014), Guilford Press
  45. Yin Q, "Pharmacological inhibition of galectin-3 ameliorates diabetes-associated cognitive impairment, oxidative stress and neuroinflammation in vivo and in vitro", J Inflamm Res, 13, pp.533~542 (2020)
  46. Ramírez E, "Neuroinflammation induced by the peptide amyloid-β(25-35)increase the presence of galectin-3 in astrocytes and microglia and impairs spatial memory", Neuropeptides, 74, pp.11~23 (2019)
  47. Chen YC, "Galectin-3 negatively regulates hippocampus-dependent memory formation through inhibition of integrin signaling and galectin-3 phosphorylation", Front Mol Neurosci, 10, pp.217~ (2017)
  48. Chen HL, "Glycobiology of the nervous system", pp.517~542 (2014), Springer
  49. Gülle ZN, "Investigation of galectin-1 and galectin-3 levels in children with autism spectrum disorder, their healthy siblings, and healthy controls", pp.2022
  50. Condray R, "Language disorder in schizophrenia as a developmental learning disorder", Schizophr Res, 73, pp.5~20 (2005)

관련 논문AI추천

Serum Galectin-3 Levels in Children with Attention-Deficit/Hyperactivity DisorderArif Demirdas¸, Evrim Aktepe, Faruk Kılıç, Pınar Aydog˘ an Avs¸ ar, Ümit Is¸ ık대한신경정신의학회 · PSYCHIATRY INVESTIGATION2020 · 제17권 제3호Higher Levels of Galectin-1 and Galectin-3 in Young Subjects with Autism Spectrum Disorder Compared to Unaffected Siblings and Healthy ControlsAli Karayagmurlu, Canan Kucukgergin, Murat Coskun, Yasar Tanir, Zeynep Nur Karadogan대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2023 · 제21권 제4호Increased Serum Level of CCL5 in Children with Attention‑Deficit/Hyperactivity Disorder: First Results about Serum ChemokinesAhmet Özaslan, Burak Arslan, Dicle Büyüktaskin, Esra Güney, Özlem Gülbahar대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2022 · 제20권 제1호Increased Serum Brain-derived Neurotrophic Factor, Nerve Growth Factor, Glial-derived Neurotrophic Factor and Galanin Levels in Children with Attention Deficit Hyperactivity Disorder, and the Effect of 10 Weeks Methylphenidate TreatmentBilal Ustundag, Cavithan Gumus, Ipek Percinel Yazici, Kemal Utku Yazici대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2022 · 제20권 제4호A Different View on the Etiopathogenesis of Attention-deficit Hyperactivity Disorder from an Inflammation PerspectiveEser Kilic, Esra Demirci, Semiha Dursun, Sevgi Ozmen대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2021 · 제19권 제1호Could Low Serum TWEAK Levels Serve as a Biomarker for Children and Adolescents Diagnosed with ADHD, Specifically the Predominantly Inattentive Subtype?Cansu Özbaş, Kübranur Ünal, Leyla Ibrahimkhanlı, Yasemin Taş Torun, Zeynep Kübra Kurt대한정신약물학회 · Clinical Psychopharmacology and Neuroscience2025 · 제23권 제4호

이 간행물의 다른 논문 (10건)